Expanded Access for IMMU-132
This is an expanded access program (EAP) for eligible participants designed to provide access to IMMU-132.
Metastatic Triple-Negative Breast Carcinoma
DRUG: IMMU-132
This is an expanded access program (EAP) for eligible participants designed to provide access to IMMU-132.